Regarding survival, the group treated with Ge/HA/CpG showed the highest survival from the beginning of the treatment in comparison to all the experimental groups; although by day 28–34 post-melanoma inoculation, both the Ge/HA/CpG- and Ge/HA/MAGE-A5-treated mice reached 25% survival, much higher than that of the other groups. Here, MAGEA5P is linked to melanoma.